Van Hoef Consulting provides services to biopharma and biotech companies in clinical development and medical affairs including pharmacovigilance and regulatory. Specialized in oncology, hematology and cell therapy.
Services are provided by Marlies Van Hoef, MD, PhD, MBA.
Phases of development: phase I-IV, observational studies.
Services for biologics, targeted and immune therapies, cell therapy and drugs including small molecules. Detailed services upon request.
M Van Hoef worked in industry, at a CRO, Swissmedic in market authorization, registries, as consultant.